From idea to ETF portfolio in minutes. Build yours now →
BioTech & Genomics ETFs
Aggregate data of 6 funds
Performance
Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +16.38% | -0.19% | +6.72% | +51.53% | +12.42% | |
| Flows | -$49M | -$142M | -$77M | -$222M | -$874M | - |
Just published in BioTech & Genomics
Are Biotechnology ETFs In the Midst of a Comeback?
Biotech stocks are under pressure in 2025, but these ETFs may offer turnaround potential.
Movers in BioTech & Genomics
Data period: April 14 - 21, 2026
Performance lists exclude leveraged and inverse ETFs
Latest news about Thematic Investing: BioTech & Genomics
Are Biotechnology ETFs In the Midst of a Comeback?
Biotech stocks are under pressure in 2025, but these ETFs may offer turnaround potential.
Biotech ETFs – Investing in Health Innovation
With biotech ETFs investors may be able to diversify and gain exposure to biotech companies with less risk and smoother long-term returns.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs
Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.
ETF Trends
ETF Industry KPIs April 20, 2026
The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.
Asset TV
The ETF Show - Investors Run to Cash Alternatives as Markets Remain Volatile
Jason England, Portfolio Manager and Fixed Income Strategist from Simplify joined The ETF Show to discuss investor allocations to fixed income as markets continue on their rollercoaster ride.
ETF Trends
ETF Industry KPIs March 30, 2026
The ETF Industry saw 33 New Launches, 1 Ticker Change and 9 closures last week.
Browse all educational columns
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
